Portable on-off visual-mode detection using intrinsic fluorescent zinc-based metal-organic framework for detection of diclofenac in pharmaceutical tablets.

On-site, robust, and quantitative detection of diclofenac (DCF) is highly significant in bioanalysis and quality control. Fluorescence-based metal-organic frameworks (MOFs) play a pivotal role in biochemical sensing, offering a versatile platform for detecting various biomolecules. However, conventional fluorescent MOF sensors often rely on lanthanide metals, which can pose challenges in terms of cost, accessibility, and environmental impact. Herein, an intrinsic blue fluorescent zinc-based metal-organic framework (FMOF-5) was prepared free from lanthanide metals. Coordination-induced emission as an effective strategy was followed wherein a non-fluorescent ligand is converted to a fluorescent one after insertion in a framework. Conventional fluorometry and smartphone-assisted visual methods were employed for the detection of DCF. The fluorescence emission of the FMOF-5 was effectively quenched upon the addition of the DCF, endowing it an "off" condition, which permits the construction of a calibration curve with a wide linear range of 30-670 µM and a detection limit of about 4.1 µM. Other analytical figures of merit, such as linearity, sensitivity, selectivity, accuracy, and precision were studied and calculated. Furthermore, the proposed sensor was successfully applied to quantify DCF in pharmaceutical tablets with reliable recovery and precision. Importantly, the elimination of lanthanide metals from the fluorescence detection system enhances its practicality and sustainability, making it a promising alternative for DCF detection in pharmaceutical analysis applications.

Antibacterial and Antioxidant Study of New Pharmaceutical Formulation of Didecyldimethylammonium Bromide Via Pharmaceutical Deep Eutectic Solvents (PDESs) Principle.

Combination therapies have been studied by many researchers using different techniques and methods to solve some solid drug problems and improve more effective treatments for humans and animals. One of the more significant findings to emerge from this study is that the combination of pharmaceutical agents by using pharmaceutical deep eutectic solvents (PDESs) in order to produce dual action drugs and reduce the drug resistance. The major objective of this study was to investigate the dual functionality of drugs (antioxidant and antibacterial activity) via the principle of PDESs. The produced PDESs were characterized via different techniques, namely differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR), and UV-Vis spectrophotometry. We herein tested a panel of novel liquid formulations of didecyldimethylammonium bromide (DDMAB) against a selection of pathogenic bacteria, classifying their spectrum of activity against Gram-positive and Gram-negative bacteria. The current study found that the PDESs can be used to produce drugs with dual functionalities. The produced PDES from (ascorbic acid: DDMAB) exhibits stronger antibacterial activity against Gram-positive Staphyloccocus aureus and Staphyloccocus epidermidis than gram negatives. One of the most interesting PDESs studied in this research was that of DDMAB and ascorbic acid. This forms a eutectic which is far from the solid drugs issues and shows dual functionality like antibacterial and antioxidant activity. This study has found that there is a correlation between the molecular docking study and the biological activities of the combined drugs.

Dual-state dual emission from precise chemically engineered bi-ligand MOF free from encapsulation and functionalization with self-calibration model for visual detection.

Synthesis of dual-state dual emitting metal-organic frameworks (DSDE-MOFs) is uncommon and challenging. Additionally, DSDE-MOFs can fulfil the expanding need for on-site detection due to their stability and self-reference for a variety of non-analyte variables. In the present work, a novel intrinsic DSDE of chemically engineered bi-ligand Eu-based MOF (UoZ-1) was designed. The prepared UoZ-1 spherical particles were small-sized around 10-12 nm and displayed blue (425 nm) and red fluorescence (620 nm) at both states, dispersed in liquid and in solid state, when excited at 250 nm. A ratiometry platform was developed since the red emission was quenched by the addition of folic acid and the blue emission was almost remained unaffected. In the fluorometric ratiometric-mode, a dynamic linear range was recorded from 10 to 200 µM with LOD about 0.4 µM. Visual-based detection with assistance of smartphone was developed for quantification based on RGB analysis using Color Grab App. In the visual-mode, LOD as small as 2.3 µM was recorded. By utilizing the intrinsic dual-emitting UoZ-1, highly stable, recyclable, sensitive, and selective on-site visual detection of folic acid can be achieved. UoZ-1, a DSDE-MOF with no encapsulation or functionalization requirements, exhibits great potential for diverse applications.